We all know about the 1st White female physician in the U.S. but no one ever talks about the Black female physician pioneers in the U.S. Check out this book to learn about them & comment below if you wanna join my book club discussion 🙂 https://amzn.to/3l77cO9
UPDATED: our massive database of PhD fellowships is available for download.
We list 195 different fellowships with description of the award, eligibility criteria, deadline and amount.
Download for free here: https://research.jhu.edu/rdt/funding-opportunities/graduate/
Our scientific seminar - Introduction to Cell and Gene Therapy, will be happening later today at 3 pm EST!
Presented by Dr. Kevin Curran
FREE to register 👉 https://caringcross.org/events/
We look forward to seeing you later!
Our latest review in place of care manufacturing is now published and open access. Thanks to Dr De Lima for his expert views- @globalgti #CARTcell https://doi.org/10.1053/j.seminhematol.2023.01.001#.Y90TEe8T0Fw.twitter
We have a new exciting series created by cell and gene industry expert Dr. Kevin Curran, starting Feb 3
Introduction to Cell and Gene Therapy
Presenter: Kevin Curran, PhD
Please register on our Events page now 👉 https://caringcross.org/events/
Understanding the phases of a clinical trial can help you decide if one is right for your child or teen. This video from @theNCI explains each phase. https://bit.ly/3WDzNYk
Vector BioMed has launched! The first B corp to be spun out of Caring Cross. With preferential pricing and access for Caring Cross projects this is an essential step in providing the tools to make cell and gene therapy accessible to all https://www.prnewswire.com/news-releases/biomanufacturing-company-vector-biomed-launches-with-mission-to-provide-access-to-high-quality-lentiviral-vectors-and-address-the-vector-supply-bottleneck-301733937.html?tc=eml_cleartime
Congrats to SickleInAfrica's Prof Julie Makani on being awarded the Ordre national du Mérite, by the Ambassador of France to Tanzania,@HajlaouiNabil. The award is a French order of merit & 2nd highest national order after the Legion of Honour. #SCD @juliemakani @FranceTanzania
Interesting story of the first person to take hydroxyurea for sickle cell disease and the intersection of science discovery and racism @SickleInAfrica @ConquerSCD @globalgti @SCDFoundation https://hub.jhu.edu/2023/01/25/sickle-cell-anemia-history/?utm_source=Alumni+-+Weekly+Update&utm_campaign=deb69e27f7-EMAIL_CAMPAIGN_2023_01_25_04_11&utm_medium=email&utm_term=0_82ece9ffab-ac0a3b1869-%5BLIST_EMAIL_ID%5D&mc_cid=deb69e27f7&mc_eid=f28ab9d33a
With two companies seeking FDA approvals for gene therapies, a cure for #SickleCellDisease may soon be available. Yet, individuals living with the disease worry about life without it and the barriers to accessing the treatment.
Read more via @nytimes.
http://bit.ly/3wegcn2
Nice quick review of current (mostly commercial) approaches to direct in vivo gene therapy https://www.biopharmadive.com/news/in-vivo-cell-therapy-car-t-biotech-startups/634287/
In 2020 the National Academy published a concise report that continues to serve as guidance for all communities impacted by sickle cell disease and remains a key guidance #Sicklecell @globalgti @ConquerSCD @theNASEM https://nap.nationalacademies.org/resource/25632/Sickle%20Cell%20Highlights_2020.pdf
In the January issue of Cancer Discovery—
Intraventricular B7-H3 #CARTcells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety, by @VitanzaNick, Michael Jensen, Julie Park et al.
https://bit.ly/3R2iQWl
@seattlechildren @SCTherapeutics #DIPG
Thanks to Dr. Karine Dube for presenting at our Jan 20 event entitled - HIV Cure Research: Scaling Up Participant-Centered Approaches, Strategic Socio-Behavioral Sciences and Ethics Research
You may access it in our Members Area; membership is FREE
👉https://caringcross.org/become-a-member/
Our exciting impact talk, "HIV Cure Research: Scaling Up Participant-Centered Approaches, Strategic Socio-Behavioral Sciences and Ethics Research," will be happening later at 3 pm EST:
Presenter: Karine Dube, DrPH / UCSD
FREE to register 👉 https://caringcross.org/events/
We have an exciting impact talk coming up this Friday, Jan 20, at 3 pm EST:
HIV Cure Research: Scaling Up Participant-Centered Approaches, Strategic Socio-Behavioral Sciences and Ethics Research
Presenter: Karine Dube, DrPH / UCSD
Register 👉 https://caringcross.org/events/
“Of all the forms of inequality, injustice in health care is the most shocking and most inhumane.” Attributed to Dr Martin Luther King Jr., at the Medical Committee of Human Rights convention, Chicago 1966. Dr. Charlene Galarneau dug a little deeper and found the actual quote….
📽️Talking everything BCMA (and a little bit of GPRC5D) with @ChrisHeery. We discuss synthetic binding domains, the viral vector shortage, utility vs CD19 CARs, and cell Tx vs bi-specifics. #JPM23
Great discussion of allo versus auto-CAR-T
📽️Talking cell therapy with Kite Pharma CEO Christi Shaw. We discuss BCMA, moving CAR-T into earlier lines of treatment, and focusing on improving auto programs vs diving more into allo. Plus a @BLLPHD shoutout. #JPM23
Hear our Executive Director, Boro Dropulic discuss the Caring Cross model to innovate, broaden access, and lower costs for cell and gene therapy, focusing on new approaches for CART for #HIVcure on @HealthProRadio Health Professionals Radio @globalgti https://healthprofessionalradio.com.au/caring-cross-car-t-as-a-potential-cure-for-hiv/
